A clinical study evaluating the safety and efficacy of Lumixyl Topical Brightening System, a non-prescription line from Envy Medical (www.lumixyl.net), revealed high patient satisfaction scores. The study, which appeared in the April 2012 issue of the Journal of Cosmetic Laser Medicine, included 15 healthy female volunteers of Asian and Caucasian descent, all with moderate to severe photodamage. After 24 weeks, 100% of patients said that their hyperpigmentation was nearly cleared or completely cleared. Additionally, physicians who examined the women found that 85% of the subjects achieved mild or completely cleared hyperpigmentation at the end of the study. The physician-evaluators used standardized photos to confirm the results.
The products were well tolerated by all study volunteers and there were no measurable side effects reported. “Lumixyl is a novel, effective and well-tolerated topical skin lightening product that serves as a great alternative for those not wanting the irritant effect of most currently available skin lightening products," said dermatologist Dr. David J. Goldberg, one of the lead authors on the study. "It is particularly valuable for treating chronic or persistent hyperpigmentation conditions, where longer term use of prescription products are a concern.”